(Q33592435)

28 July 2017

1 reference

title

Reteplase: a new thrombolytic for the treatment of acute myocardial infarction (English)

1 reference

acute myocardial infarction

28 July 2017

1 reference

1 reference

M B Wooster

1

1 reference

PubMed ID

10200858

28 July 2017

A B Luzier

series ordinal

2

1 reference

PubMed ID

10200858

28 July 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

Annals of Pharmacotherapy

28 July 2017

1 reference

28 July 2017

33

1 reference

28 July 2017

3

1 reference

28 July 2017

318-324

1 reference

Reteplase. A review of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction

28 July 2017

1 reference

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

21 January 2018

1 reference

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

21 January 2018

1 reference

A faster-acting and more potent form of tissue plasminogen activator

21 January 2018

1 reference

Molecular biology of plasminogen activators: what are the clinical implications of drug design?

21 January 2018

1 reference

The open-artery theory is alive and well--again

21 January 2018

1 reference

A comparison of reteplase with alteplase for acute myocardial infarction

21 January 2018

1 reference

More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators

21 January 2018

1 reference

Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.18006

1 reference

28 July 2017

1 reference

PubMed ID

10200858